TRXC earnings call for the period ending June 30, 2019.
News & Analysis: TransEnterix
The Senhance Surgical System's launch isn't progressing nearly as well as investors had hoped.
Investors cheered the surgical robot maker's sale of assets and the added cash the divestiture will bring.
Investors were none too pleased with the robotic surgery specialist's first-quarter earnings report.
Japanese approval for its robotic surgical system provides a nice spark to the medical device stock.
Should you be as excited as the analysts who think these stocks are two-baggers in the making?
An analyst upgrade fueled optimism for the beaten-down stock.
Sales of the company's Senhance robotic surgery system took a discouraging dip in the first quarter.
TRXC earnings call for the period ending March 31, 2019.
TRXC earnings call for the period ending December 31, 2018.